Holen Sie sich die Stockscreener-App
1.3959
0.75%
-0.0155
Schlusskurs vom Vortag:
$1.3804
Offen:
$1.37
24-Stunden-Volumen:
22,615
Relative Volume:
0.03
Marktkapitalisierung:
$2.44M
Einnahmen:
$90,700
Nettoeinkommen (Verlust:
$-3.43M
KGV:
-0.8582
EPS:
-1.6266
Netto-Cashflow:
$-4.65M
1W Leistung:
+5.38%
1M Leistung:
-12.18%
6M Leistung:
-51.93%
1J Leistung:
-89.71%
1-Tages-Spanne:
$1.31
$1.43
1-Wochen-Bereich:
$1.215
$1.47
52-Wochen-Spanne:
$1.0332
$18.36
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Rating Reiterated by HC Wainwright - Defense World
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
60 degrees pharmaceuticals director buys $8,500 in stock By Investing.com - Investing.com Canada
60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com India
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3.1% - Defense World
60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com
SXTPW60 Degrees Pharmaceuticals, Inc. Warrant Latest Stock News & Market Updates - StockTitan
60 Degrees Pharmaceuticals Announces Closing of $4 Million Private Placement - citybiz
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 - GlobeNewswire
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - StockTitan
60 Degrees Pharmaceuticals to raise $4M via private placement; shares fall - MSN
60 Degrees Pharmaceuticals announces private placement sale - Investing.com India
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement - TipRanks
60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Australia
60 Degrees Pharmaceuticals announces private placement sale - Investing.com
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com UK
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - StockTitan
60 Degrees Pharmaceuticals Inc (SXTP)’s Day in Review: Closing at 1.34, Down by -11.84 - The Dwinnex
TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewswire
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - StockTitan
60 Degrees Pharmaceuticals regains compliance with Nasdaq listing requirements - TipRanks
60 Degrees Pharmaceuticals Inc Share PriceSXTP, RNS News, Articles, Quotes, & Charts (NASDAQ: SXTP) - Proactive Investors Australia
60 Degrees Pharmaceuticals Reports Doubling of Q2 2024 Revenues and Advances Clinical Trials - Proactive Investors Australia
60 Degrees Pharmaceuticals Reports Doubling of Q2 2024 Revenues and Advances Clinical Trials - Proactive Investors UK
60 Degrees Pharmaceuticals Inc Share PriceSXTP, RNS News, Articles, Quotes, & Charts (NASDAQ: SXTP) - Proactive Investors UK
60 Degrees Pharmaceuticals Inc’s Mixed Bag: Down -39.50% in 6 Months, Down -7.00% in 30 Days - The InvestChronicle
Market Resilience: 60 Degrees Pharmaceuticals Inc (SXTP) Finishes Strong at 1.58, Up 1.28 - The Dwinnex
60 Degrees Pharmaceuticals Inc (SXTP)’s stock price range in the last year - US Post News
Q3 2024 EPS Estimates for 60 Degrees Pharmaceuticals, Inc. Boosted by Analyst (NASDAQ:SXTP) - Defense World
60 Degrees Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Stock Rating Reaffirmed by HC Wainwright - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Issues Quarterly Earnings Results - Defense World
Financial Contrast: 60 Degrees Pharmaceuticals (NASDAQ:SXTP) and Antibe Therapeutics (OTCMKTS:ATBPF) - Defense World
60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com Australia
60 Degrees Pharmaceuticals reports doubled Q2 revenue - Investing.com
60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - citybiz
Thinking about buying stock in Nio Inc, 60 Degrees Pharmaceutica - GuruFocus.com
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
60 Degrees Pharmaceuticals reports doubled Q2 revenue - Investing.com India
60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com Canada
SXTP60 Degrees Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - ForexTV.com
60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com UK
60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - GlobeNewswire
60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - Yahoo Finance
60 Degrees Pharmaceuticals Inc (SXTP) is looking forward to a strong quarter - SETE News
Should You Add 60 Degrees Pharmaceuticals, Inc. (SXTP) to Your Stock Portfolio Right Now? - Insider Monkey
Should You Add 60 Degrees Pharmaceuticals, Inc. (SXTP) to Your Stock Portfolio Right Now? - Yahoo Finance
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
60 Degrees Pharmaceuticals Inc-Aktie (SXTP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
May 16 '24 |
Option Exercise |
0.22 |
2,000 |
446 |
228,934 |
| FIELD PAUL | Director |
May 16 '24 |
Option Exercise |
0.22 |
4,000 |
892 |
14,000 |
| DOW GEOFFREY S | President and CEO |
Apr 12 '24 |
Option Exercise |
0.27 |
68,000 |
18,142 |
745,625 |
| DOW GEOFFREY S | President and CEO |
May 16 '24 |
Option Exercise |
0.22 |
17,000 |
3,791 |
762,625 |
| Allen Charles W | Director |
May 16 '24 |
Option Exercise |
0.22 |
4,000 |
892 |
14,000 |
| DOW GEOFFREY S | President and CEO |
Jan 31 '24 |
Buy |
0.38 |
25,974 |
9,740 |
703,599 |
| XU CHERYL | Director |
Jan 31 '24 |
Buy |
0.38 |
200,000 |
75,000 |
424,934 |
1.25%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):